Literature DB >> 21424989

Suitability of the anterolateral thigh perforator flap and the soleus perforator flap for intraoral reconstruction: a retrospective study.

Klaus-Dietrich Wolff1, Frank Hölzle, Andreas Kolk, Bettina Hohlweg-Majert, Marco Rainer Kesting.   

Abstract

Perforator flaps are suitable for numerous reconstructive purposes. However, there are few data about their usefulness for intraoral reconstruction. We reviewed data of 101 patients who were reconstructed by two types of perforator flaps after oral cancer. Forty-six soleus perforator flaps and fifty-five anterolateral thigh (ALT) perforator flaps were performed. Procedural data and outcome measures were analyzed. One ALT and four soleus perforator flaps were lost, resulting in success rates of 97.8% and 91.4%, respectively. Soleus perforator flaps were more challenging due to short and small-caliber vessels, higher susceptibility to vascular spasm, and difficult prediction of the location of the vascular pedicle. All donor sites in both groups except one were closed directly, and their morbidity was negligible. Perforator flaps from both donor sites can be used for intraoral reconstruction with good functional results; however, despite primary thinning, the ALT flap can be voluminous in small and flat defects. Here, soleus perforator flaps adapt better to the oral mucosa. The ALT perforator flap is more reliable and serves as a safe alternative to the radial forearm flap. © Thieme Medical Publishers.

Entities:  

Mesh:

Year:  2011        PMID: 21424989     DOI: 10.1055/s-0031-1275485

Source DB:  PubMed          Journal:  J Reconstr Microsurg        ISSN: 0743-684X            Impact factor:   2.873


  2 in total

1.  [The soleus muscle flap].

Authors:  J Hankiss; C Schmitz
Journal:  Oper Orthop Traumatol       Date:  2013-04       Impact factor: 1.154

Review 2.  Full-Thickness Oral Mucoperiosteal Defects: Challenges and Opportunities.

Authors:  Brittany N Allen; Qi Wang; Yassine Filali; Kristan S Worthington; Deborah S F Kacmarynski
Journal:  Tissue Eng Part B Rev       Date:  2022-01-24       Impact factor: 7.376

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.